SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-331879
Filing Date
2013-08-13
Accepted
2013-08-13 08:26:33
Documents
11
Period of Report
2013-08-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d583672d8k.htm 8-K 19668
2 EX-3.1 d583672dex31.htm EX-3.1 3596
3 EX-3.2 d583672dex32.htm EX-3.2 36917
4 EX-3.3 d583672dex33.htm EX-3.3 378745
5 EX-99.1 d583672dex991.htm EX-99.1 3639
6 GRAPHIC g583672ex3_1pg001a.jpg GRAPHIC 7670
7 GRAPHIC g583672ex3_1pg001b.jpg GRAPHIC 38225
8 GRAPHIC g583672ex3_1pg001c.jpg GRAPHIC 3673
9 GRAPHIC g583672ex3_2pg001an.jpg GRAPHIC 10348
10 GRAPHIC g583672ex3_2pg001b.jpg GRAPHIC 2711
11 GRAPHIC g583672ex99_1logo.jpg GRAPHIC 14952
  Complete submission text file 0001193125-13-331879.txt   551824
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 131031330
SIC: 2834 Pharmaceutical Preparations